Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Ischemia

• Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5
• Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
• Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment for
• Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
• Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
• Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke
• Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke
• EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)
• The Effect of GD-iExo-003 in Acute Ischemic Stroke
• Safety and Efficacy of Urinary Kallidinogenase for Large Artery Atherosclerosis Acute Ischemic Stroke
• Phase 2 Study of TXA127 in Post-ischemic Stroke Patients
• Effects of Human Urinary Kallidinogenase on Early Improvement and Functional Outcomes in Acute Ischemic Stroke (TK-SPEED)
• Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke
• Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization
• Efficacy and Safety of Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke Combined With Type 2 Diabetes Mellitus
• The Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile
• Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
• A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)
• Predictors of AIS Unfavorable Outcomes
• Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy
• Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
• Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
• Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)
• Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L)
• Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
• A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
• Intra-arterial Thrombolysis After Successful Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation (IAT-TOP)
• Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
• Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)
• TRPM8 in Acute Ischemic Stroke by Topical Menthol
• Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
• RESTORE: buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
• Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
• The Effects of Cilostazol Dexborneol on Microcirculation Dysfunction and Thrombo-inflammation in Patients With Acute Ischemic Stroke After Reperfusion Therapy
• Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy
• Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke
• Application of Sodium Bicarbonate Ringer's Solution in Laparoscopic Hepatectomy
• The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment
• Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke: A Randomized Controlled Clinical Trial
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
• A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well
• Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
• Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
• Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
• Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）
• Safety and Efficacy Study of Levofloxacin Combined With Endovascular Thrombectomy for Acute Ischemic Stroke
• Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic Stroke
• Satralizumab in Aneurysmal Subarachnoid Hemorrhage
• Multicentre Randomized Trial of Ghrelin in Anterior Circulation Ischemic Stroke Treated With Endovascular Thrombectomy. A Randomized Phase 2 Trial
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
• rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)
• Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy
• Safety and Efficacy of Evolocumab in Ischemic Stroke
• Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery
• A Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
• A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke
• A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled t
• Trial of Intra-arterial Tenecteplase Following Successful Endovascular Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke
• Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization
• The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke
• Mechanism of Cardiac and Cerebral Function Injury Caused by Intraoperative Limb Ischemia-reperfusion
• Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke
• Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke
• Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
• Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy
• MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial
• Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
• Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass
• Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
• A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke
• Analyzing the Pharmacodynamic Substances and the Effects of Yiqihuayu Decotion for Acute Ischemic Stroke (PHYSIS)
• Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke
• Ticagrelor Versus Clopidogrel in Ischemic Stroke
• Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia
• Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke
• A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
• A Multicenter, Randomized Trial to Assess Safety, and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
• A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation
• Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)
• ProUrokinase in Mild IsChemic strokE (PUMICE)
• Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy
• EVALUATION OF LOW DOSE COLCHICINE AND TICAGRELOR IN PREVENTION OF ISCHEMIC STROKE IN PATIENTS WITH STROKE DUE TO ATHEROSCLEROSIS
• Blocking the Effects of Serotonin to Prevent Ischemic Mitral Regurgitation: a Randomized Trial
• A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
• Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Children
• Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys
• Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
• Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at High Risk of Developing Malignant Brain Edema
• Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting
• Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial
• Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke
• Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery
• Study to Evaluate The Safety and Efficacy of Balovaptan in Patients With Acute Ischemic Stroke at High Risk of Developing Malignant Brain Edema
• Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER)
• PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
• A Study of r-PA Treating Patients With Acute Ischemic Stroke
• Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）
• Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)
• Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)
• Treatment of Acute Ischemic STroke With Edaravone Dexborneol II
• The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)
• FIH (First in Human) Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation
• The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke
• ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion
• Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction
• Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.
• Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
• Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT
• Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke
• A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke
• Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke
• A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
• Citicoline in Ischemic Stroke
• Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation
• Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III
• Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.
• Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT
• BUN/Cr-based Hydration Therapy to Improve Outcome of Patients With Acute Ischemic Stroke
• Adaptive Efficacy and Safety Study of Glenzocimab Used as an add-on Therapy on Top of Standard of Care un the 4.5 Hours Following an Acute Ischemic Stroke
• Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction
• Treatment of Acute Ischemic Stroke (ReMEDy II Trial)
• Intracranial Stenting in Non-acute Symptomatic Ischemic Stroke
• Effects of Vasopressor on the Graft Blood Flow in TRAM
• Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz
• Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke
• Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention
• Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver Transplantation
• Evaluation of Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal Arterial Occlusion
• Protective Effects of Edaravone Dexborneol
• Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction
• Hypertonic Lactate After Cardiac Arrest
• Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema
• 24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial
• Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm
• Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
• A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
• Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
• An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
• Study on the Effectiveness and Safety of Nitrone for Injection in Patients With Acute Ischemic Stroke
• Clinical Study of Cinepazide Maleate Injection in the Treatment of Acute Ischemic Stroke
• Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
• A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment
• Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke
• Effect of Prolonged Sedation With Dexmedetomidine on Long-term Prognosis of Patients With Acute Ischemic Stroke After Mechanical Thrombectomy
• Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.
• SY007 in Patients With Acute Ischemic Stroke
• Combination of the Immune Modulator Dimethyl Fumarate With Intraarterial Treatment in Acute Ischemic Stroke
• Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke
• Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke
• Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)
• One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China
• Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)
• Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke
• Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows
• Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke
• Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke
• Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ
• Efficacy of Pulmozyme® on Arterial Recanalization in Post-thrombectomy Patients Managed for Ischemic Stroke (NETs-target)
• Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial
• Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
• NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
• Efficacy of Ticagrelor Plus Aspirin in Minor Non-cardioembolic Ischemic Stroke
• Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
• Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
• Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI
• Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)
• REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts
• Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT)
• Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)
• European Blood Pressure Intensive Control After Stroke
• NVD in Hypothermic HIE Neonates
• A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
• Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)
• Endovascular Treatment and RIPC in Acute Ischemic Stroke
• Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
• Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients
• Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine
• Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
• Role of Sympathetic Activation in Ischemia Reperfusion Injury
• Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
• Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)
• Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia
• The Efficacy and Safety of Sofadil for Injection in the Treatment of Acute Ischemic Stroke
• PeRiOperaTivE CardioproTection With Ivabradine in Non-cardiac Surgery
• Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
• The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
• HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia
• Growth Hormone in Ischemic Heart Failure
• Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke
• Intravenous Magnesium Sulphate in Acute Ischemic Stroke
• Cardio-Cerebrovascular Co-Prevention and Co-Management Based on Internet+
• Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)
• Sildenafil for Treatment of Choroidal Ischemia
• Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography
• An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.
• Alprostadil as an Adjuvant Therapy With Indirect Angiosomal Revascularization in Critical Limb Ischemia.
• A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke
• Dexmedetomidine on Tourniquet Induced -Systemic Effects
• Effect of Evolocumab in Patients With Critical Limb Ischemia (Evol-CLI)
• Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the
• Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia
• Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke
• Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
• Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke
• Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
• Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
• Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA
• Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.
• Effect of Colchicine in Patients With Myocardial Infarction
• Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study
• NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events
• Outcome in Patients Treated With Intraarterial Thrombectomy - optiMAL Blood Pressure Control (OPTIMAL-BP)
• Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Intra-arterial Cocktail Therapy (INSIST-CT)
• Boosting REcanalization of Thrombectomy for Ischemic Stroke by Intra-arterial TNK (BRETIS-TNK)
• Improving Neuroprotective Strategy for Ischemic Stroke With Poor Recanalization After Thrombectomy by Intra-arterial TNK (INSIST-TNK)
• Evidence-based Evaluation of TCM Key Syndrome Differentiation and Treatment for Acute Ischemic Stroke
• Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization
• Xingnaojing for Mild-to-severe Acute Ischemic Stroke
• One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
• Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke
• Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease
• Evaluation of Safety and Tolerability of Libella Gene Therapy for Critical Limb Ischemia: AAV- hTERT
• Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome of Acute Ischemia Stroke Patients
• A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
• Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
• PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
• Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
• A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke.
• Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
• Effects of Selenium and Melatonin on Ocular Ischemic Syndrome
• Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke
• Trial to Assess Chelation Therapy in Critical Limb Ischemia
• Personalized Antiplatelet Secondary Stroke PRevenTion
• Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia
• Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI
• Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
• A Study of NCS-01 in Patients With Acute Ischemic Stroke
• Caffeine for Hypoxic-Ischemic Encephalopathy
• Ticagrelol Versus Aspirin in Ischemic Stroke
• INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE
• Effects of Ivabradine on Residual Myocardial Ischemia After PCI
• Benign Prostatic Hyperplasia and Ischemic Heart DIsease
• The Norwegian Tenecteplase Stroke Trial 2
• Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
• Desflurane Preconditioning in Hepatectomies
• Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)
• Exercise-induced Ischemia and the Influence of Pain Modulation in a Nerve Growth Factor (NGF) Model
• The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement
• Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke
• Acute Ischemic Stroke Interventional Study
• Fascia Iliaca Block for Anesthesia in Lower Limb Thromboembolectomy
• EVOlocumab in Stable Heart Failure With Reduced Ejection Fraction of Ischemic Etiology: EVO-HF Pilot
• Sevoflurane vs Propofol Effect on Endothelial Damage Markers After Knee Ligament Surgery.
• A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
• The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques
• Multi-arm Optimization of Stroke Thrombolysis
• Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.
• Oxygen Therapy for Retinal Ischemia
• NAION Treatment With Oral Prednisolone and Erythropoietin Injection
• Treatment of No-option CLI by G-CSF-mobilized PB-MNC
• RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
• A Safety and Tolerability Study of RJX Drug Product in Healthy Participants
• Intravenous Estrogen in Kidney Transplant Study
• Ozone Therapy in Refractory Ischemic Heart Disease.
• Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke
• Imatinib in Acute Ischaemic Stroke
• Investigation of Neural Stem Cells in Ischemic Stroke
• Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
• Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
• CEUS Evaluation of Hypoxic Ischemic Injury
• Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
• Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
• A Polypill for Secondary Prevention of Ischemic Heart Disease
• Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment
• A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
• Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction
• Nutrition in Patient With Critical Limb Ischemia
• 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease
• Effect of Trimetazidine on the Improvement of Coronary Microvascular Dysfunction in Patients With INOCA(Ischemia and no Obstructive Coronary Artery Disease)
• Penumbral Rescue by Normobaric O2 Administration in Patients With Ischemic Stroke and Target Mismatch ProFile
• Clinical Study of Lipoic Acid on Ischemic Heart Failure
• Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction
• The Effect of Pregabalin Given Preoperatively on the Tourniquet Induced Ischemia-reperfusion
• Interaction Between NGF and Acute Exercise-induced Ischemia
• Autologous Stem Cells for the Treatment of No Option Critical Limb Ischemia
• Fluoxetine Opens Window to Improve Motor Recovery After Stroke
• Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation
• Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial
• Chelation Therapy in Diabetic Patients With Critical Limb Ischemia
• Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)
• Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions
• Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
• Effectiveness of Butylphthalide on Dynamic Cerebral Autoregulation in Patients With Acute Ischemic Stroke.
• Efficacy of High and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcome in Patients With AIS
• Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
• Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients
• Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome
• Tirofiban for Patients Treated With Alteplase
• THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
• Verapamil for Neuroprotection in Stroke
• Dose Finding Study of MCI-186 in Acute Ischemic Stroke
• Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)
• Neuroprotection in Acute Ischemic Stroke
• Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial
• Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke
• Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke
• Trial of EXenatide in Acute Ischaemic Stroke
• DNS-3379 vs. Placebo in Stroke Rehabilitation
• N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes
• Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve
• Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)
• Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy
• Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke
• CES1 Carriers in the PAPI Study
• Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy
• Tenecteplase in Wake-up Ischaemic Stroke Trial
• Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor
• The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
• Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
• Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome
• Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya
• PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes
• Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS
• Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
• Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes
• The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
• PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns
• Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
• Optimal Antithrombotic Therapy in Ischemic Stroke Patients With Non-Valvular Atrial Fibrillation and Atherothrombosis
• Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
• Stem Cell Heart Injections During Laser Revascularization Surgery for Treatment of Chronic Ischemic Heart Disease
• Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction
• Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation
• Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance
• Mild Hypothermia After Endovascular Treatment in Acute Ischemic Stroke
• Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery
• Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?
• Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study
• Effect of Sedatives on Regional Cerebral Oxygen Saturation
• A Phase Ib/II in Patients With Acute Ischemic Stroke
• Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
• Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
• Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
• Early Administration of Aspirin in Patients With Acute Ischemic Stroke Treated With Systemic Thrombolysis
• Anesthetics to Prevent Lung Injury in Cardiac Surgery
• Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study.
• The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males
• Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)
• Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells
• Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke
• Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset
• Dietary Nitrate Supplements and Ischemic Stroke Recovery
• STREAMER : STent Restenosis And MEdicaments Release
• Effects of Dexmedetomidine on the Liver Injury After Hepatectomy
• Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC)
• Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)
• Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke
• Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response
• Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
• Proteomics and Stem Cell Therapy as a New Vascularization Strategy
• Study of Efficacy and Safety of MEXIDOL®
• Plerixafor in Diabetic Wound Healing
• Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
• A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes
• Clopidogrel for Acute Ischaemia of Recent Onset
• Effects of Preoperative Fasting on ECG and Vital Parameters
• The Effect of Anesthetics Agents on Vascular Injury and Level of Syndecan-1 During Knee Surgery
• Basilar Artery Occlusion Chinese Endovascular Trial
• Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
• Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS)
• Impact of Variable Types of Preconditioning Upon the Inotrope Score in Adult Patients, Undergoing Cardiac Surgery
• Genotyping Influences Outcome of Coronary Artery Stenting
• Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations
• Predictive Factors of Intestinal Infraction in Acute Mesenteric Ischemia
• Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients
• Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
• General Anesthesia for Endovascular Thrombectomy; A Pilot Study.
• Ultrasound to Enhance Paclitaxel Uptake in Critical Limb Ischemia: the PACUS Trial
• Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
• Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics
• ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)
• Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
• Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm
• The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment
• A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA
• Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
• Preconditioning With Sevoflurane and Propofol in Patients Undergoing Minimally Invasive Mitral Valve Surgery
• AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
• Cerebrolysin REGistry Study in Stroke
• Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome
• HT-3951 vs. Placebo in Stroke Rehabilitation
• Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia
• A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.
• Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
• Selenium and Ischemic Stroke Outcome
• The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.
• Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)
• PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
• Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization
• Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization
• A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia
• Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI
• Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)
• Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device
• Helping Stroke Patients With ThermoSuit Cooling
• Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
• Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke
• Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy
• Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy
• Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
• Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
• Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
• Use Art-assist and Neupogen to Treat Chronic Limb Ischemia
• Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery
• Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol
• Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke
• ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
• Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia
• DLBS1033 for the Treatment of Acute Ischemic Stroke
• Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
• Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke
• Chest Pain Perception and Capsaicin Sensitivity in Patients With Acute Cardiac Ischemia
• Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
• Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease
• Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM
• Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION
• Field Randomization of NA-1 Therapy in Early Responders
• Liraglutide to Improve corONary Haemodynamics During Exercise streSS
• The Effects of Intravenous Heme Arginate on Heme Oxygenase-1 Expression (HO-1) and Oxidative Stress in the Human Heart
• Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke
• Dexmedetomidine Effect on Mitochondrial Function
• Comparison of Biomatrix and Orsiro Drug Eluting Stent
• Dabigatran Following Transient Ischemic Attack and Minor Stroke
• Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin
• Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers
• A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.
• Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia
• Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury
• Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
• Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)
• Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance
• Superselective Administration of VErapamil During Recanalization in Acute Ischemic Stroke
• Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia
• Atorvastatin in Acute Stroke Treatment
• Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions
• Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage
• Safety Evaluation of 3K3A-APC in Ischemic Stroke
• Edoxaban for TIA and Acute Minor Stroke
• Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
• Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia
• Tadalafil in Becker Muscular Dystrophy
• Pilot Study of Atorvastatin for Orthopedic Surgery Patients
• Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
• Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke
• Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass
• Evaluate the Efficacy of Bu-Yang- Huan-Wu Tang（BYHWT）on Ischemic Stroke
• The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
• Assessment of Blood-Borne Autologous Angiogenic Cell Precursors Therapy in Patients With Critical Limb Ischemia
• Study on Therapeutic Effect of Treating Mental Stress Induced Myocardial Ischemia
• DLBS1033 for Acute Ischemic Stroke Patients
• Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
• XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke
• The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium
• Protective Effects of L-arginine During Reperfusion by Femoropopliteal Bypass for Lower Limb Ischemic Syndrome in Humans
• Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke
• Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
• Evaluation of MST-188 in Acute Lower Limb Ischemia
• Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study
• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke
• Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
• Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic Stroke
• Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).
• Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
• To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI Bleed
• Arginase Inhibition in Ischemia-reperfusion Injury
• Randomized Controlled Study of the Effectiveness of IV Fluid Infusion in Patients With Acute Ischemic Stroke (IVIS)
• [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
• ISCHEMIA-Chronic Kidney Disease Trial
• Effect of Ranolazine on Valvular Disease in Patients With Pacemakers
• A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
• Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture
• A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.
• Intensive Insulin Treatment and Ischemic Foot Ulcer
• Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
• Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke
• Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke
• Antinociceptive Modalities on Ischemia Reperfusion Injury
• Compound Edaravone Injection for Acute Ischemic Stroke
• Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease
• Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure
• Tongxinluo Capsule in Ischemic Stroke Patients（TISS)
• Sevoflurane Protective Effect on Ischemia-reperfusion Injury. Multicenter, Randomized Controlled Trial
• Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy
• Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers
• A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke
• Improving Patient Access to Stroke Therapy Study
• Feasibility Study of IV Recombinant Tissue Plasminogen Activator (rtPA) vs. Primary Endovascular Therapy for Acute Ischemic Stroke
• Safety Study of Melatonin in Stroke Patients
• Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
• Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
• The Use of Carbon Dioxide as a Contrast Media for Performing Endovascular Procedures
• Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke
• Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions
• Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke
• Mildronate for Acute Ischemic Stroke
• Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
• Impact of Ranolazine on Coronary Microcirculatory Resistance
• Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
• Efficacy and Safety of Mildronate for Acute Ischemic Stroke
• Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia
• Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
• Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
• Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage
• Statin Therapy In Atrial Refractoriness and Reperfusion Injury
• Dynamic Combination Therapy on Chinese Herbal Granules to Improve the Symptoms in Convalescent Phase of Ischemic Stroke
• The Elderly ACS II Trial
• Ischaemia-réperfusion During the Coronary Surgery With Beating Heart
• Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke
• Clinical Impact of the Withdrawal of Nitrate in Patients With Stable Angina
• Effect of EECP on Anterior Ischemic Optic Neuropathy
• Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy
• Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke
• Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke
• Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery
• Pragmatic Ischaemic Stroke Thrombectomy Evaluation
• Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
• Limitation of Ischemic Injury of a Kidney Stored in Machine Perfusion in Hypothermia - Evaluation of the Impact on Kidney Allograft Function
• Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
• Qutenza for Critical Ischaemia in End Stage Renal Failure
• Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
• Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
• Efficacy of BNG-1 to Treat Acute Ischemic Stroke
• Ischemia Reperfusion: Prostaglandins and Antioxidants
• Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
• Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI
• TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion
• Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy
• Effect of F2695 on Functional Recovery After Ischemic Stroke
• The Effect of Propofol Infusion on Total Antioxidant Status During Tourniquet-Induced Ischemia-Reperfusion Injury
• Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia
• A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol in Intracranial Surgery
• The Metformin-FMD Trial
• Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%
• Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes
• A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
• Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan
• Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler
• Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction
• Xarelto [SPAF] Post-marketing Surveillance in Japan
• TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion
• Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
• Use of Minocicline in Patients With Stroke
• Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure
• Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke
• Ranolazine for Improving Symptoms of Palpitations
• Treatment of Vasopressor-induced Ischemia With Botulinum Toxin A
• Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
• Heme Arginate in Functional Magnetic Resonance Imaging (fMRI)
• Iloprost Therapy in Patients With Critical Limb Ischemia
• Renal Graft Function After Treatment With Erythropoietin (EPO)
• Desflurane Versus Propofol in the Sitting Position
• Induction of HO-1; a Therapeutic Approach to Reduce Ischaemia Reperfusion Injury (IRI) Following Deceased Donor Renal Transplantation
• Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
• Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)
• NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement
• Remote Ischemic Preconditioning in Coronary Artery Bypass Grafting With Cold Crystalloid Cardioplegic Arrest
• Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery Disease
• Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium
• Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event.
• Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
• Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo
• Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral Oxygenation
• Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?
• A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
• Glyburide Advantage in Malignant Edema and Stroke Pilot
• The Safety of Vardenafil in Patients Undergoing Cardiac Surgery
• Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients
• Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)
• Safety and Efficacy of Topiramate in Neonates With Hypoxic Ischemic Encephalopathy Treated With Hypothermia
• Thymoglobulin Induction in Kidney Transplant Recipients
• Comprehensive Evaluation of Ischemic Heart Disease Using MRI
• Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)
• N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection
• Efficiency Study of Siwu Tang to Treat Brain Hypoperfusion Syndrome
• Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
• Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot
• Distal Venous Arterialisation of Ischemic Limb
• Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
• Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease
• The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)
• The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction
• Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries
• Evaluation of Myocardial Ischemia Using Standard Single Photon Emission Computed Tomography (SPECT) With Regadenoson and Simultaneous Cardiac Echocardiography
• Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
• Dapsone for Acute Ischemia Stroke Study
• Glutamate and Diastolic Function in Patients Undergoing Aortic Valve Repair
• A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
• Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
• Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke
• The Effects of C-type Natriuretic Peptide on Human Forearm Blood Vessels
• Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
• Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet
• Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients
• Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy
• Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy
• Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging
• PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
• Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass
• Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
• Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
• Hyperglycemia in a Coronary Intensive Care Unit
• Statin Drugs to Prevent Complications During Surgery
• Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke
• The Effect of Ischaemic-Reperfusion and Remote Ischaemic Preconditioning in Man - A Bradykinin Dependent Pathway
• The Effect of Ischaemic-Reperfusion in Man - A Bradykinin Dependent Pathway
• Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
• Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation
• Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)
• Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy
• Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack
• AXIS 2: AX200 for the Treatment of Ischemic Stroke
• A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia
• Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke
• Evaluation of the Effects of Oxygen Therapy and Enalapril for Diabetic Macular Ischemia
• Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
• Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
• Mesenchymal Stem Cells in Critical Limb Ischemia
• Effect of Xenon and Therapeutic Hypothermia, on the Brain and on Neurological Outcome Following Brain Ischemia in Cardiac Arrest Patients
• YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation
• Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke
• Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke
• The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke
• PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
• Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
• Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke
• Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery
• Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
• Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility Study
• Enoxaparin and/or Minocycline in Acute Stroke
• Urokinase Therapy in Patients With Diabetic Foot Syndrome
• Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
• Trial to Evaluate the Ability of a Single Infusion of High-Density Lipoprotein (HDL) to Modulate Markers of Cerebral Ischaemia
• Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke
• The DIEP Flap as a Model of Ischemia-Reperfusion: an Intervention Study
• VISSIT Intracranial Stent Study for Ischemic Therapy
• Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke
• Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy
• An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
• Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery
• Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy
• Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery
• Cardiac Effects of Oxytocin Administrated During Cesarean Section, Signs of Myocardial Ischemia
• Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion
• Platelet Hyperreactivity to Aspirin and Stroke
• METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial)
• Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke
• A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement
• The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)
• Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure
• Comparison of Two Strategies for Glycemic Control in Acute Ischemic Stroke
• A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
• The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial
• Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients
• Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
• Assessment of Oxygen Changes in the Heart With Cardio-vascular Magnetic Resonance Imaging
• Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model
• Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)
• PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina
• Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease
• Fluoxetine on Motor Rehabilitation After Ischemic Stroke
• Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure
• The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial
• Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke
• Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia
• Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy
• IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion
• Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)
• Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation
• Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study
• Ginsenoside-Rd for Acute Ischemic Stroke
• Responses of Myocardial Ischemia to Escitalopram Treatment
• Microvascular Coronary Disease In Women: Impact Of Ranolazine
• A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow
• Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy
• Beta-blocker Before Extubation
• Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy
• A Multiple-Centered, Prospective Cohort Study: the Second Prevention Trial for Ischemic Stroke With Deng Zhan Sheng Mai Capsule（SPIRIT-DZSM-2）
• Urokinase Therapy in Diabetic Foot Syndrome
• The Effects of Post-Conditioning and Administration of Vitamin C on Intramuscular High Energy Phosphate Levels
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)
• Effects of Sevoflurane in Subanesthetic Concentrations on the Forearm Perfusion
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)
• Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke
• Transcranial Ultrasound in Clinical SONothrombolysis
• Glutamate for Metabolic Intervention in Coronary Surgery
• Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke
• Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
• Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
• Model System for Transient Forearm Blood Vessel Dysfunction
• Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke
• UT-15C SR in the Treatment of Critical Limb Ischemia
• Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?
• A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI
• A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI
• Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
• Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
• Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
• Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty
• Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty
• Study of Aspirin and TPA in Acute Ischemic Stroke
• Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial
• Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
• Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion
• The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.
• Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb Ischemia
• A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
• Efficiency of a New Therapy to Treat Stenosis of Coronary Vessels in Comparison With Two Already Admitted Therapies
• Comparison of Anti-Ischemic Drug Therapy and Percutaneous Transluminal Angioplasty After Myocardial Infarction
• Study to Investigate Effects of Antiischemic Drug Therapy in Silent Ischemia
• Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches
• Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack
• hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP)
• Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)
• ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"
• Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
• EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine)
• Quality Improvement in Stroke Prevention (QUISP)
• Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury
• The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance
• Rosuvastatin and Ischemia Reperfusion
• Melatonin Treatment and Inflammation, Oxidative Stress and Autonomic Function in Connection With Surgery
• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
• Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia
• Caffeinol Hypothermia Protocol
• ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation
• Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB
• Argatroban Stroke Treatment - A Pilot Safety Study
• FOCUS:Focus On Coronary Unstable Syndromes
• The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress
• Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation
• Albumin in Acute Ischemic Stroke Trial
• Induced Hypertension for Acute Ischemic Stroke
• Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation
• "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
• Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)
• Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke
• EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia
• Opioid Receptors Influence Ischemia-Reperfusion Injury
• The Effect of Caffeine on Ischemic Preconditioning
• Adenosine Receptors Influence Ischemia-Reperfusion Injury
• Ischemic Injury and Ischemic Preconditioning in Diabetes
• AMP as a Better Delivery System of Adenosine
• EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study
• ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial
• MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)
• QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia
• Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke
• Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
• Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
• Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth
• Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
• Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
• Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)
• Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.
• Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes
• EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)
• Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery
• PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)
• A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)
• Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft
• Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
• Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
• Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
• Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation
• Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
• Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
• Repinotan in Patients With Acute Ischemic Stroke
• A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
• SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
• Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
• Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients With Coronary Artery Disease
• Electromechanical Mapping to Evaluate Heart Muscle
• Long Term Effects of Enalapril and Losartan on Genetic Heart Disease
• CVD Risk and Health in Postmenopausal Phytoestrogen Users
• Women's Health Initiative (WHI)
• Magnesium in Coronaries (MAGIC)
• Estrogen and Graft Atherosclerosis Research Trial (EAGER)
• Cholesterol-Lowering Atherosclerosis Study (CLAS)
• NHLBI Type II Coronary Intervention Study
• Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
• Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
• Women's Angiographic Vitamin and Estrogen Trial (WAVE)
• HDL-Atherosclerosis Treatment Study (HATS)
• Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
• Estrogen Replacement and Atherosclerosis (ERA) in Older Women
• Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
• Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
• Tamoxifen Study
• Cardiac Arrhythmia Suppression Trial (CAST)
• Studies of Left Ventricular Dysfunction (SOLVD)
• Familial Atherosclerosis Treatment Study
• Platelet-Inhibitor Drug Trial in Coronary Angioplasty
• Intravenous Streptokinase in Acute Myocardial Infarction
• Thrombolysis in Myocardial Infarction (TIMI)
• Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
• Physicians' Health Study
• Platelet Drug Trial in Coronary Disease Progression
• Multicenter Investigation of Limitation of Infarct Size (MILIS)
• Beta-Blocker Heart Attack Trial (BHAT)
• Aspirin-Myocardial Infarction Study (AMIS)
• Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)
• Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)
• Coronary Drug Project Mortality Surveillance
• Coronary Drug Project
• Multicenter Unsustained Tachycardia Trial (MUSTT)
• Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
• Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
• Cholesterol Reduction in Seniors Program (CRISP)
• Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
• Thrombolysis in Myocardial Ischemia Trial (TIMI III)
• Myocardial Infarction Triage and Intervention Project (MITI)
• Postmenopausal Estrogen/Progestin Interventions (PEPI)
• Post Coronary Artery Bypass Graft (CABG) Study
• Harvard Atherosclerosis Reversibility Project (HARP)